Generic Name and Formulations:
Metronidazole 1.3%; vaginal gel; contains parabens.
Indications for NUVESSA:
Bacterial vaginosis in non-pregnant women.
One applicatorful once daily at bedtime.
<18yrs: not established.
Concomitant or within 2 weeks of disulfiram use. Concomitant alcohol and preparations containing ethanol or propylene glycol during and for ≥24hrs after treatment.
Not for ophthalmic, dermal, or oral use. CNS diseases. Pregnancy (Cat.B). Nursing mothers: not recommended (may pump/discard milk during and for 24hrs after therapy ends).
See Contraindications. May potentiate oral anticoagulants, lithium. May be potentiated by cimetidine. May interfere with serum chemistry tests.
Vulvovaginal candidiasis, headache, vulvovaginal pruritus, nausea, diarrhea, dysmenorrhea.
Gel—5g (w. applicator)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Healthcare Community Should Favor More Restrictive Alcohol Policies
- How to Respond to a Patient's Request for Prayer: A Clinician's Dilemma
- Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of Big Data
- ACA Coverage Gains Include Workers Without Insurance
- Steps Provided for Discharging Patients From Practice